Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

Failure Rate of DePuy ASR XL Hip Implant Rising

March 31, 2011 12:35 pm | by Bio-Medicine.Org | News | Comments

FORT WORTH, Texas, March 31, 2011 /- Recent information presented at the British Hip Society Annual Conference held from March 2 -4, 2011 indicates a rise in the failure rate of the DePuy ASR XL Acetabular Hip Replacement System which was manufactured and marketed by DePuy Orthopaedics,...

Reportlinker Adds Cardiac Marker Diagnostic Testing Markets

March 31, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, March 31, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Cardiac Marker Diagnostic Testing Markets http://www.reportlinker.com/p089570/Cardiac-Marker-Diagnostic-Testing-Markets.html The purpose of this TriMark Publications...

Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing

March 31, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, March 31, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Molecular Diagnostics in Infectious Disease Testing http://www.reportlinker.com/p0368860/Molecular-Diagnostics-in-Infectious-Disease-Testing.html This TriMark...

Advertisement

2011 ACCF/AHA Guidelines Incorporate New Recommendation for Platelet Reactivity Testing

March 31, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, March 31, 2011 /- Accumetrics, Inc., developer of the VerifyNow® System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced today that a new recommendation for platelet reactivity testing has...

Nile Therapeutics Receives Fast Track Designation for Cenderitide for Post-Acute Indication

March 31, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

SAN MATEO, Calif., March 31, 2011 /- Nile Therapeutics, Inc. (Nasdaq: NLTX ), a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Nile's post-acute...

Lilly's Connecting Hearts Abroad Program Sends Employees on Global Service Assignments

March 31, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, March 31, 2011 /- Eli Lilly and Company's (NYSE: LLY ) new global service program, Connecting Hearts Abroad, is set to launch. Through the program, the company is sending 200 Lilly Ambassadors to assist people and communities that often lack basic resources. While serving...

Long-Term Data on QNEXA® to be Presented at The American College of Cardiology Annual Meeting

March 31, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., March 31, 2011 /- VIVUS, Inc. (Nasdaq: VVUS ) today announced that data on QNEXA®, its investigational drug candidate, will be featured in a poster presentation at the 60th Annual Scientific Meeting of The American College of Cardiology, being held April 2-5,...

Regado Biosciences to Present at the Needham & Company's 10th Annual Healthcare Conference in New York City

March 30, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

BASKING RIDGE, N.J., March 30, 2011 /- Regado Biosciences, a privately held company pioneering the development of antithrombotic aptamers with active control agents, announced that David J. Mazzo, PhD, President and CEO, will be presenting at the Needham & Company's 10th Annual...

Advertisement

Regeneron Announces Presentation at the 10th Annual Needham Healthcare Conference

March 30, 2011 6:31 am | by Bio-Medicine.Org | News | Comments

TARRYTOWN, N.Y., March 30, 2011 /- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) will webcast its presentation at the 10th Annual Needham Healthcare Conference on Wednesday, April 6, 2011 at 1:20 p.m. Eastern Time.  The session may be accessed through the Company's web site,...

Premier Heart to Exhibit its Multifunction CardioGram (MCGâ„¢) at American College of Cardiology in New Orleans April 2-5

March 30, 2011 6:31 am | by Bio-Medicine.Org | News | Comments

PORT WASHINGTON, N.Y., March 30, 2011 /- Premier Heart, LLC is proud to be exhibiting the Multifunction CardioGram at ACC 11, the 60th Annual Scientific Sessions and Expo of the American College of Cardiology to be held April 2-5, 2011 in New Orleans. The MCG offers completely...

Abaxis, Inc. to Present at the 10th Annual Needham Healthcare Conference

March 30, 2011 6:31 am | by Bio-Medicine.Org | News | Comments

UNION CITY, Calif., March 30, 2011 /- Abaxis, Inc. (Nasdaq: ABAX ), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, chairman and chief executive officer,  will present at the 10th Annual Needham Healthcare Conference...

Fujifilm Highlights Synapse® 3D at ACC

March 30, 2011 6:31 am | by Bio-Medicine.Org | News | Comments

STAMFORD, Conn., March 30, 2011 /- Attendees of the 60th annual American College of Cardiology (ACC) Scientific Session in New Orleans, La., can see first hand the benefits of Synapse® 3D from FUJIFILM Medical Systems U.S.A., Inc. Available for sale in the U.S., Synapse 3D is a...

Major China Regenerative Medicine Company Adopts ThermoGenesis Cord Blood Stem Cell Processing And Storage Technologies

March 30, 2011 5:36 am | by Bio-Medicine.Org | News | Comments

RANCHO CORDOVA, Calif., March 30, 2011 /- ThermoGenesis Corp. (Nasdaq: KOOL ), a leading supplier of innovative products and services that process and store adult stem cells, said today that Nanshan Memorial Medical Institute (Nanshan), a leading regenerative medicine company, will be...

Advertisement

Nile Therapeutics Announces Upcoming Data Presentation at the American College of Cardiology Annual Scientific Meeting

March 30, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

SAN MATEO, Calif., March 30, 2011 /- Nile Therapeutics, Inc. (Nasdaq: NLTX ), a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced the schedule of its upcoming cenderitide presentation taking place at the American College of Cardiology...

Isis Pharmaceuticals to Present at the 10th Annual Needham Healthcare Conference

March 30, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., March 30, 2011 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at Needham's 10th Annual Healthcare Conference on Wednesday, April 06, 2011 at 10:40 a.m. ET at the New...

MicroCHIPS Announces 35th U.S. Patent for Microreservoir-Based Drug Delivery Systems

March 29, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

WALTHAM, Mass., March 29, 2011 /- MicroCHIPS, Inc., a developer of innovative drug delivery devices and biosensors, today announced that the U.S. Patent Office and Trademark Office has granted U.S. Patent No. 7,892,221, Method of Controlled Drug Delivery from Implant Device. This patent...

GSK and Valeant Receive European Authorisation for Trobalt (retigabine)

March 29, 2011 9:37 am | by Bio-Medicine.Org | News | Comments

LONDON and MISSISSAUGA, Ontario, March 29, 2011 /- GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: VRX) announced today that the European Commission has granted marketing authorisation for Trobalt™ (retigabine) as an adjunctive (add-on)...

Promidian Survey Finds Growing Support for Patient-Centered Medical Home

March 29, 2011 9:37 am | by Bio-Medicine.Org | News | Comments

BERKELEY HEIGHTS, N.J., March 29, 2011 /- Promidian, a management consulting firm focused on the pharmaceutical and biotechnology industries, today announced top-line survey findings about the increasing interest in the patient-centered medical home (PCMH), a patient-centric...

Boston Scientific Announces Its ACC 2011 Schedule

March 29, 2011 4:36 am | by Boston Scientific | News | Comments

Clinical presentations to include 12-month data on PROMUS Elementâ„¢ Platinum Chromium Stent

Initiation of FLINT Announced by NIDDK: Study of Intercept Pharmaceuticals' Obeticholic Acid (INT-747) in NASH

March 29, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, March 29, 2011 /- Intercept Pharmaceuticals, Inc., has been informed by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health that patient enrollment has started in a new clinical trial in patients with nonalcoholic...

BioDrain Medical, Inc. Completes Installation of Its Streamwayâ„¢ Automated Surgical Fluid Disposal System in Minnesota Hospital

March 29, 2011 2:34 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, March 29, 2011 /- BioDrain Medical, Inc. (OTC Bulletin Board: BIOR ), producer of the FDA cleared Streamway™ System for automated surgical fluid disposal, announced today that it has completed the installation of its patented Streamway™ System in a large Minnesota...

A Genetic Test for Organ Rejection

March 28, 2011 8:34 pm | by Massachusetts Institute of Technology | News | Comments

Rising levels of donor DNA in recipients' blood could mean the organ is in danger.

Penn Researchers Analyze Conflicts of Interest in Cardiovsacular Care Guidelines

March 28, 2011 12:35 pm | by University Of Pennsylvania | News | Comments

A new analysis by researchers at the University of Pennsylvania School of Medicine of recent cardiology clinical practice guidelines has found that more than half of the experts involved in the development of these guidelines reported a conflict of interest (COI).

New Harvard-MIT device to detect single cancer cells

March 28, 2011 10:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

A new microfluidic device that can detect single cancer cells in blood, potentially telling doctors if cancer has spread, has been developed jointly by professors at Harvard Medical School and MIT.

Detroit Medical Center Becomes First in Southeast Michigan to Study an Implantable Device, Designed to Reduce Patient Time to the ER and Improve Survival Rates From Heart Atta...

March 28, 2011 10:36 am | by Bio-Medicine.Org | News | Comments

DETROIT, March 28, 2011 /PRNewswire-USNewswire/ -- Detroit Medical Center (DMC) Cardiovascular Institute (CVI) announced its first implant of the AngelMed Guardian cardiac monitor and alert system. The system is designed to reduce the time it takes patients to get to the emergency room...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading